Drug Shortage Report for MINT-LOSARTAN
| Report ID | 113187 |
| Drug Identification Number | 02405741 |
| Brand name | MINT-LOSARTAN |
| Common or Proper name | losartan |
| Company Name | MINT PHARMACEUTICALS INC |
| Market Status | MARKETED |
| Active Ingredient(s) | LOSARTAN POTASSIUM |
| Strength(s) | 50.0MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
|
Packaging sizes (GTIN)
Click here to see a list of all reports for this drug. |
(See additional packaging sizes) |
| Additional packaging sizes | 100 count bottles |
| ATC code | C09CA |
| ATC description | ANGIOTENSIN II ANTAGONISTS, PLAIN |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2019-09-27 |
| Estimated end date | |
| Actual end date | 2024-03-22 |
| Shortage status | Resolved |
| Updated date | 2024-12-05 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 6575 DAVAND DRIVE MISSISSAUGA, ONTARIO CANADA L5T 2M3 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v4 | 2024-12-05 | French | Compare |
| v3 | 2024-12-05 | English | Compare |
| v2 | 2020-04-25 | French | Compare |
| v1 | 2020-04-25 | English | Compare |
Showing 1 to 4 of 4